No Association of Serum Gonadal or Pituitary Hormones With Prognostic Parameters in Stages T1 to T3 PN0M0 Prostate Cancer

Abstract

Serum levels reflecting the pituitary-gonadal axis at diagnosis are not associated with clinically used measures of tumor aggressiveness (T category, Gleason score or PSA) in patients with newly diagnosed T1 to T3 pN0M0 prostate cancer.